MedTrace Logo

Prospective Evaluation of the Diagnostic Efficacy of a EUS Guided FNB Needle (AQUIRE®)

NCT03621852 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2018-08-09

No results posted yet for this study

Summary

The present study investigates the efficacy of a new Endoultrasound guided fine needle biopsy (EUS-FNB) device (AquireTM Boston Scientific= AQUIRE®) for obtaining histological tissue cylinders in the diagnosis of solid pancreatic tumors, submucosal tumors of the upper gastrointestinal tract (esophagus, stomach, duodenum) and lymph node disease..

Conditions

  • Tumors of the Pancreas
  • Submucosal Tumor of Gastrointestinal Tract (Disorder)
  • Lymph Node Disease

Interventions

DEVICE

Endoultrasound guided FNB

EUS FNB with Aquire TM device

Sponsors & Collaborators

  • Philipps University Marburg

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-01
Primary Completion
2019-07-01
Completion
2020-07-01
FDA Device
Yes

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03621852 on ClinicalTrials.gov